Beyond Chronic Diarrhoea: A Practical Diagnostic Approach to Canine Inflammatory Bowel Disease

Canine Inflammatory Bowel Disease (IBD) remains one of the most underdiagnosed causes of chronic gastrointestinal disease in veterinary practice. This article discusses a practical diagnostic approach to canine IBD, including clinical presentation, laboratory markers, fecal evaluation, and the importance of inflammatory biomarkers and vitamin profiling in identifying disease severity and intestinal involvement. 

Inflammatory Bowel Disease (IBD), also referred to as Chronic Enteropathy (CE), represents a group of chronic inflammatory disorders characterized by infiltration of inflammatory cells within the intestinal mucosa¹. Although considered relatively common in referral gastroenterology practice, IBD in dogs often remains overlooked in general practice because of overlapping clinical signs with dietary intolerance, parasitic enteritis, infectious diseases, and other chronic gastrointestinal disorders. 

The condition can involve any part of the gastrointestinal tract and may progress to severe complications, including gastrointestinal bleeding, stenosis, obstruction, perforation, and sepsis if persistent inflammation remains uncontrolled². In chronic cases, repeated mucosal injury and impaired intestinal microcirculation may significantly worsen prognosis. 

Recognising the Clinical Pattern 

The clinical presentation of canine IBD is highly variable and often fluctuating. Dogs commonly present with chronic vomiting, small bowel diarrhoea, melena, weight loss, borborygmus, abdominal discomfort, and flatulence. In some cases, large bowel diarrhoea associated with mucus, fresh blood, tenesmus, and urgency may predominate. Interestingly, pica behaviour, particularly grass eating, has also been observed in affected dogs¹. 

While no definitive breed, age, or sex predisposition has been established, IBD appears more frequently reported in breeds such as German Shepherds, Labradors, Rottweilers, Dobermans, Pugs, Lhasa Apsos, Cocker Spaniels, and non-descript dogs³. 

Because clinical signs alone are non-specific, a systematic diagnostic workup becomes essential. 

Clinical Scoring and Disease Assessment 

The Canine IBD Activity Index (CIBDAI) remains one of the most practical clinical tools for assessing disease activity and monitoring treatment response. The scoring system evaluates six major clinical variables and helps clinicians objectively grade disease severity¹. 

In clinical practice, serial CIBDAI scoring can be particularly useful for: 

• Monitoring therapeutic response  

• Assessing relapse severity  

• Guiding long-term management decisions  

Laboratory Findings: What Should Raise Suspicion? 

Routine haemato-biochemistry may not always provide definitive answers, but certain abnormalities can strengthen clinical suspicion. 

Neutrophilia, occasionally with a left shift, may be observed in inflammatory cases. However, hypoalbuminaemia is among the most clinically significant findings and has been associated with poorer prognosis in canine IBD¹. Hypocholesterolaemia may further support underlying malabsorption, while hypocalcaemia and hypomagnesaemia can occur in chronic enteric disease. 

Among inflammatory markers, C-Reactive Protein (CRP) has gained importance as an indicator of systemic inflammation. Dogs with IBD have been reported to show markedly elevated CRP concentrations, averaging 24.39±2.48 mg/dL in one clinical observation^1,3. Elevated CRP may therefore support assessment of disease severity and inflammatory burden. 

Folate and Cobalamin: Valuable Yet Underutilized Markers 

Assessment of serum folate and cobalamin concentrations offers important insight into the location and extent of intestinal involvement. 

Reduced folate concentrations are suggestive of proximal small intestinal disease, whereas decreased cobalamin levels indicate distal intestinal involvement. Simultaneous reduction of both markers may indicate diffuse intestinal inflammation¹. 

In chronic gastrointestinal cases with weight loss and poor body condition, these markers can significantly improve diagnostic confidence while also helping guide nutritional support strategies. 

Fecal Evaluation Still Matters 

Despite advances in diagnostic imaging and laboratory testing, fecal examination remains a critical component of IBD workup. Direct smear and flotation techniques help exclude parasitic causes including protozoal and nematode infections that may mimic chronic enteropathy. 

Additional fecal diagnostics may include: 

• Fecal culture for enteropathogens such as Salmonella spp. and Campylobacter spp.  

• Fecal cytology using rectal scraping and Diff-Quik staining  

• Fecal scoring, where scores of 6–7 have commonly been associated with canine IBD cases⁴  

Conclusion 

Diagnosing canine IBD requires a combination of clinical suspicion, exclusion of other gastrointestinal diseases, and interpretation of inflammatory and malabsorption markers. Persistent diarrhoea, vomiting, weight loss, elevated CRP, hypoalbuminaemia, and altered folate-cobalamin concentrations together can significantly strengthen diagnostic suspicion before confirmatory investigations are pursued. In day-to-day veterinary practice, integrating clinical scoring systems such as CIBDAI with routine laboratory and fecal evaluation can improve early recognition and long-term disease monitoring in affected dogs. 

References 

1. Bhoya SD, Patel MA, Mehta SA, Mavadiya SV, Patel MD. Inflammatory bowel diseases in dogs. Int J Vet Sci Anim Husb. 2024;9(2):303-306. https://www.researchgate.net/profile/Manish-Patel-7/publication/379837811_Inflammatory_bowel_diseases_in_dogs/links/661e177666ba7e2359dd3292/Inflammatory-bowel-diseases-in-dogs.pdf 

2. Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nature reviews Gastroenterology & hepatology. 2021 Jan;18(1):56-66. https://pmc.ncbi.nlm.nih.gov/articles/PMC7542092/pdf/41575_2020_Article_360.pdf 

3. Bhavani SM, Kavitha S, Vairamuthu S, Vijayarani K, Bhat A. Clinical signs, activity indices and prognostic indicators in dogs with idiopathic inflammatory bowel Disease. Indian J Anim Res. 2023;57(11):1544-1549. DOI: https://doi.org/10.18805/IJAR.B-4399 

4. Burton EN, O'Connor E, Ericsson AC, Franklin CL. Evaluation of fecal microbiota transfer as treatment for postweaning diarrhea in research-colony puppies. Journal of the American Association for Laboratory Animal Science: JAALAS. 2016 Sep;55(5):582. https://pmc.ncbi.nlm.nih.gov/articles/PMC5029830/pdf/jaalas2016000582.pdf